Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
While no clinical trials directly compare the medications, these two recent studies provide insights into common results
Participants who stopped GLP-1 medications regained weight at an average rate of 0.4 kg per month, and for those on semaglutide and tirzepatide, the medications most commonly covered in employer benefits today, that rate doubled, with return to baseline weight projected at about 1.5 years
A stall is different from normal weekly fluctuations
For instance, a randomized placebo-controlled trial conducted by Faurschou et al 14 examined the effect of liraglutide on psoriasis in glucose-tolerant patients
US$ 20.24
US$ 20.71
US$ 25.50
US$ 26.45
US$ 22.73
